Is neurohormonal activation a major determinant of the response to ACE inhibition in left ventricular dysfunction and heart failure?
Sigurdsson
A
A
Department of Medicine, University of Gothenburg, Ostra Hospital, Sweden.
Swedberg
K
K
D000804:Angiotensin II / Q000097:blood; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D006333:Heart Failure / Q000097:blood* / Q000188:drug therapy; D006801:Humans; D009203:Myocardial Infarction / Q000097:blood* / Q000188:drug therapy / Q000401:mortality; D016032:Randomized Controlled Trials as Topic; D012084:Renin-Angiotensin System / Q000187:drug effects*; D013564:Sympathetic Nervous System / Q000187:drug effects; D018487:Ventricular Dysfunction, Left / Q000097:blood* / Q000188:drug therapy
D000806:Angiotensin-Converting Enzyme Inhibitors; D000804:Angiotensin II